Skip to main content Talk to a certified wellness coach free — a real 15-minute call, no cost, no card. Book your free call
OS Reboot
See if you qualify

Zepbound at a glance

Eli Lilly's brand-name tirzepatide — an FDA-approved dual GIP/GLP-1 injection for chronic weight management, the same molecule as Mounjaro. Supplied only when a physician finds it appropriate. Nothing is prescribed unless a licensed physician determines it is appropriate for you.

Protocol
Zepbound
Category
Branded GLP-1
Medicine type
Injection
Availability
Prescription only. An FDA-approved medication, supplied only where a licensed physician determines it is appropriate after an individual evaluation.
Dispensed by
A U.S. state-licensed pharmacy.

About Zepbound

What it is

Zepbound is brand-name tirzepatide — a dual GIP/GLP-1 agonist that acts on two gut-hormone pathways rather than one. It is FDA-approved for chronic weight management in adults who meet the labelling criteria, used with a reduced-calorie diet and more activity.

How it is used

A weekly injection, prescribed only after a physician evaluates you individually.

What to discuss with your physician

Tell your physician about thyroid cancer or MEN 2 in your family, pancreatitis, gallbladder or kidney disease, and any pregnancy plans. Ask how the routine is adjusted over time.

Educational information only. It is not medical advice and does not describe results you should expect. A licensed physician decides what, if anything, is appropriate for you.

Zepbound, explained

What Zepbound is

Zepbound is the brand name for tirzepatide, a dual GIP/GLP-1 receptor agonist — it acts on two of the body's appetite- and metabolism-regulating hormone pathways rather than one. It is FDA-approved for chronic weight management in adults with obesity, or with overweight plus at least one weight-related condition, as an adjunct to a reduced-calorie diet and increased physical activity, and is taken as a once-weekly injection by pre-filled pen.

What its clinical trial showed

In SURMOUNT-1, the pivotal 72-week trial, adults taking the highest studied dose of tirzepatide alongside a reduced-calorie diet and increased physical activity saw an average total body-weight reduction of 20.9% — the largest figure reported in a pivotal trial of any medication carried here. It is a trial average, not a prediction of your result. Individual results vary, not everyone qualifies, and no outcome is guaranteed.

How you get it

You complete a private online evaluation, and a state-licensed physician in the affiliated medical network reviews your health history. Zepbound is prescription-only: it is prescribed only if that physician determines it is appropriate for you, and you are charged for medication only after a prescription is issued. If prescribed, it ships from a U.S. state-licensed pharmacy.

Common questions

Is Zepbound FDA-approved?
Yes. Zepbound (tirzepatide) is FDA-approved for chronic weight management, as an adjunct to a reduced-calorie diet and increased physical activity.
How is Zepbound different from a GLP-1?
Tirzepatide is a dual GIP/GLP-1 receptor agonist — it works on two hormone pathways rather than one. Whether that matters for you is a clinical judgment your physician makes.
Do I need a prescription?
Yes. A licensed physician reviews your evaluation and prescribes only if it is appropriate for you — not everyone qualifies.

Educational information only — not medical advice, a diagnosis, or a prescription, and no outcomes or weight-loss guarantees are made or implied. Every medical decision is made by a licensed physician based on your individual history. Medications carry risks and side effects — see the important safety information on this page. Not everyone qualifies.

osrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosrebootosreboot